1. Home
  2. CORT vs OSK Comparison

CORT vs OSK Comparison

Compare CORT & OSK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Corcept Therapeutics Incorporated

CORT

Corcept Therapeutics Incorporated

N/A

Current Price

$113.05

Market Cap

9.7B

Sector

Health Care

ML Signal

N/A

Logo Oshkosh Corporation

OSK

Oshkosh Corporation

N/A

Current Price

$147.03

Market Cap

9.4B

ML Signal

N/A

Company Overview

Basic Information
Metric
CORT
OSK
Founded
1998
1917
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Auto Manufacturing
Sector
Health Care
Consumer Discretionary
Exchange
Nasdaq
Nasdaq
Market Cap
9.7B
9.4B
IPO Year
2001
2009

Fundamental Metrics

Financial Performance
Metric
CORT
OSK
Price
$113.05
$147.03
Analyst Decision
Buy
Buy
Analyst Count
5
14
Target Price
$96.50
$166.79
AVG Volume (30 Days)
805.4K
573.4K
Earning Date
04-30-2026
05-08-2026
Dividend Yield
N/A
1.55%
EPS Growth
N/A
N/A
EPS
0.09
1.14
Revenue
$761,407,000.00
$7,705,500,000.00
Revenue This Year
$26.08
$5.94
Revenue Next Year
$26.98
$7.19
P/E Ratio
$1,259.44
$135.18
Revenue Growth
12.79
12.83
52 Week Low
$28.66
$116.77
52 Week High
$126.38
$180.49

Technical Indicators

Market Signals
Indicator
CORT
OSK
Relative Strength Index (RSI) 51.71 43.07
Support Level $77.73 $146.50
Resistance Level $122.21 $158.91
Average True Range (ATR) 4.04 4.76
MACD -1.68 -0.71
Stochastic Oscillator 15.22 4.24

Price Performance

Historical Comparison
CORT
OSK

About CORT Corcept Therapeutics Incorporated

Corcept Therapeutics Inc is a commercial-stage pharmaceutical company engaged in the discovery and development of medications that treat severe metabolic, oncologic, and neuropsychiatric disorders by modulating the effect of the cortisol hormone. The company markets Korlym (mifepristone) tablets and its authorized generic version, which is an oral medication for the treatment of hypercortisolism (also known as Cushing's syndrome). Additionally, its pipeline contains several key compounds, such as Relacorilant, Dazucorilant, Miricorilant, etc., that are being evaluated in clinical trials as potential treatments for a variety of serious disorders like hypercortisolism, solid tumors (including ovarian, endometrial, cervical, pancreatic, and prostate cancers), ALS, and MASH.

About OSK Oshkosh Corporation

Oshkosh is a leading maker of access equipment, specialty vehicles, and military trucks. It serves diverse end markets, including postal, firefighting, refuse/recycling collection, aviation, and construction. It is typically the market share leader or No. 2 player in North America, or even the global leader in the case of its JLG aerial work platform business. The transport segment is a leading provider of light trucks to the military and vehicles to the Postal Service. The vocational segment, featuring brands such as Pierce, AeroTech, and Volterra, offers purpose-built vehicles and equipment to municipalities. The company reports three segments—Access equipment (45% of revenue), Vocational (35%), and Transport (20%) on 2025 revenue of $10.4 billion.

Share on Social Networks: